Annual Secretarial Compliance Report for the year ended 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended 31 March 2025, issued by Practicing Company Secretary Mr. Amit Anand. The report confirms that the company has fully complied with SEBI regulations, LODR requirements, and applicable Secretarial Standards during the review period. No deviations, penalties, or actions by SEBI/Stock Exchanges were reported against the company, its promoters, directors, or subsidiaries. All key areas — including insider trading, related party transactions, board evaluations, timely disclosures, and website maintenance — were found to be in compliance. The company has no material subsidiaries and no statutory auditor resignations during the year.
This is a routine regulatory filing with no negative observations, confirming clean compliance status. It carries no material impact on shareholders or the stock price, though it reflects positively on the company's governance standards.